GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment
GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment
Recruiting · NCT07193134 · Registry updated 2026-03-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment | Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hallopeau-Siemens Disease, Skin Abnormalities, Skin and Connective Tissue Diseases, connective tissue disorder, epidermolysis bullosa, epidermolysis bullosa dystrophica, hereditary disease, hereditary skin disorder, recessive dystrophic epidermolysis bullosa, skin disorder, vesiculobullous skin disease | Recruiting | Phase 1 / Phase 2 | 2026-03-18 | NCT07193134 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CHU de Quebec-Universite Laval | 54 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Hospital for Sick Children (SickKids) | Toronto | Canada | 3 |